My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zinbryta



Biogen Idec LimitedEU/1/16/1107/003-004

Main Information

Trade NameZinbryta
Active SubstancesDaclizumab
Dosage FormSolution for injection in pre-filled pen
Licence HolderBiogen Idec Limited
Licence NumberEU/1/16/1107/003-004

Group Information

ATC CodeL04AC Interleukin inhibitors
L04AC01 daclizumab

Status

License statusWithdrawn
Withdrawn Date27/03/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - HCP

Physician Guide

Educational Materials - Patient

Acknowledgement Form
Patient Alert Card
« Back
Follow medicine

Print